Below are full profiles from other companies in related areas ...

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies.

Eli Lilly has shared one-year histologic outcomes from a phase 3 study of its interleukin-23p19 antagonist mirikizumab in ...

• Mtech Access – Powered by Petauri™ are excited to be returning to ISPOR Europe this November. The team will be joined by ...

Roche has presented positive two-year results from an ongoing study of its spinal muscular atrophy (SMA) treatment Evrysdi ...

Up to 20% of patients will develop metastatic castration-resistant disease within five to seven years of diagnosis ...

Last chance to register for our exclusive webinar, “Why Patient Perspectives Matter: Driving Success in Clinical Trials”!

Johnson & Johnson’s (J&J) Tecvayli (teclistamab) has been recommended by the National Institute for Health and Care ...

UBM Medica is a leading healthcare media company providing bespoke solutions to a global healthcare market. We provide reference data, decision support solutions, news and education to communities of ...

Roche’s PI3K inhibitor Itovebi (inavolisib) has been approved by the US Food and Drug Administration (FDA) as part of a ...

Eli Lilly has partnered with insitro to advance new treatments for metabolic diseases, including metabolic ...